Alderley Park Preclinical Oncology Workshop

Logo
Presented by

Kinga Bercsenyi, Champions Oncology & Juliana Maynard, Medicines Discovery Catapult

About this talk

This Preclinical Oncology Workshop is for private viewership and is available only by invitation. Part 1: PDX for oncology drug development: from high-content Ex Vivo 3D imaging to biomarker discovery High-throughput 3D PDX ex vivo screen is an excellent tool for lead candidate or indication selection, keeping the clinic in sight from the very first experiment and thus enhancing the chances of success. In this webinar we are going to discuss how to use PDX models both ex vivo and in vivo, and take an idea from its creation, all the way through to the bedside – we will look at AI-powered Biomarker Discovery through an Olaparib case study, and showcase the planning and execution of preclinical and translational experiments using PDX models by looking at real life examples. Part 2: Using Imaging to enhance your Oncology Pre-Clinical Studies Applying imaging to in-vivo Oncology studies can provide key information on tumour growth and characterisation in a tissue specific location that is not possible with simple calliper measurements. This webinar provides an overview and discussion of how the Medicines Discovery Catapult is applying imaging to provide cost effective insight into Oncology studies.
Related topics:

More from this channel

Upcoming talks (1)
On-demand talks (64)
Subscribers (3414)
Champions Oncology delivers innovative solutions to oncology drug development, accelerating the journey from the research bench to the clinic – decreasing timelines, lowering costs, and ultimately saving patient lives. Learn more about Champions Oncology's capabilities, our service platforms and educational topics affecting our industry on our Webinar Channel.